# TPD52L2

## Overview
TPD52L2 is a gene that encodes the protein TPD52-like 2, which is a member of the TPD52 protein family. This protein is primarily involved in intracellular processes such as vesicle trafficking, cell proliferation, and apoptosis, playing a crucial role in maintaining cellular homeostasis and signaling. TPD52-like 2 is predominantly localized in the cytoplasm and associated with membrane-bound organelles, indicating its involvement in intracellular transport and communication pathways. The protein's functions are significant in the context of cancer biology, as it is implicated in several oncogenic signaling pathways, including PI3K-Akt, IL-17, Wnt, and Hippo, which are essential for tumor progression and immune modulation (Wang2023TPD52L2). Additionally, TPD52L2's expression levels have been linked to various cancers, where it serves as a potential prognostic biomarker due to its association with tumor stage, grade, and immune cell infiltration (Lu2024Overexpression; Zhong2021TPD52L2).

## Structure


## Function
TPD52L2 encodes a protein that is involved in several critical cellular processes, including vesicle trafficking, cell proliferation, and apoptosis. The protein is predominantly active in the cytoplasm and is associated with membrane-bound organelles, indicating its role in intracellular transport and signaling pathways. TPD52L2's involvement in vesicle trafficking suggests it plays a part in the movement and sorting of vesicles within the cell, which is essential for maintaining cellular homeostasis and facilitating communication between different cellular compartments.

In terms of cell proliferation, TPD52L2 may influence the rate at which cells divide, which is crucial for tissue growth and repair. Its role in apoptosis, or programmed cell death, indicates that TPD52L2 is involved in regulating cell survival, ensuring that damaged or unnecessary cells are efficiently removed. This balance between cell proliferation and apoptosis is vital for normal development and preventing diseases such as cancer.

The protein's association with intracellular signaling pathways suggests it may have a broader impact on cellular communication and response to external stimuli, potentially influencing immune responses and cancer progression. These functions highlight the importance of TPD52L2 in maintaining cellular and organismal health.

## Clinical Significance
The TPD52L2 gene has been implicated in various cancers due to its altered expression levels. In clear cell renal cell carcinoma (ccRCC), TPD52L2 is overexpressed at both mRNA and protein levels, correlating with malignant clinical features such as tumor stage and grade. High TPD52L2 expression is associated with shorter overall survival and progression-free survival, suggesting its role as a potential oncogene and prognostic biomarker in ccRCC (Wang2023TPD52L2). The gene's expression is linked to several signaling pathways, including PI3K-Akt and Wnt, which are involved in tumor progression and immune activity regulation (Wang2023TPD52L2).

In head and neck squamous cell carcinoma (HNSCC), TPD52L2 is also overexpressed and associated with poor prognosis. Its expression is negatively correlated with immune cell infiltration, indicating a role in immune evasion. TPD52L2 is linked to immune checkpoint markers, suggesting potential implications for immunotherapy (Lu2024Overexpression).

In lung adenocarcinoma (LUAD), TPD52L2 overexpression correlates with poorer survival outcomes and is associated with immune cell infiltration, particularly with immunosuppressive cells. This suggests a role in creating an immunosuppressive tumor environment, further highlighting its potential as a prognostic biomarker (Zhong2021TPD52L2).

## Interactions
TPD52L2, a member of the TPD52 protein family, is involved in various protein interactions that influence cellular processes. It has been identified as a binding partner of microRNA-217 (miR-217) in human pancreatic adenocarcinoma, where miR-217 targets the 3'UTR of TPD52L2 mRNA, leading to the inhibition of cell proliferation, invasion, and migration (Chen2017MicroRNA217). This interaction suggests a regulatory role of miR-217 in modulating TPD52L2 expression and its associated cellular effects.

In the context of cancer, TPD52L2 is implicated in several signaling pathways, including the PI3K-Akt, IL-17, Wnt, and Hippo pathways, which are crucial for tumor progression and immune microenvironment modulation (Wang2023TPD52L2). These pathways highlight TPD52L2's role in oncogenic processes and its potential as a therapeutic target.

TPD52L2 is also associated with immune cell infiltration in tumors, correlating with increased regulatory T cell infiltration and decreased M1 macrophage infiltration, indicating its involvement in the immune microenvironment of tumors (Wang2023TPD52L2). These interactions underscore TPD52L2's significance in cancer biology and its potential as a biomarker for prognosis and therapy.


## References


[1. (Lu2024Overexpression) Min Lu, Haoyu Xia, Jing Xu, Zijun Liao, Yuwen Li, and Hanwei Peng. Overexpression of tpd52l2 in hnscc: prognostic significance and correlation with immune infiltrates. BMC Oral Health, October 2024. URL: http://dx.doi.org/10.1186/s12903-024-04977-1, doi:10.1186/s12903-024-04977-1. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12903-024-04977-1)

[2. (Wang2023TPD52L2) Hongbo Wang, Zhendong Liu, Yuelin Du, Xingbo Cheng, Shanjun Gao, Yanzheng Gao, and Panfeng Shang. Tpd52l2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma. Frontiers in Oncology, November 2023. URL: http://dx.doi.org/10.3389/fonc.2023.1210910, doi:10.3389/fonc.2023.1210910. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2023.1210910)

[3. (Zhong2021TPD52L2) Anyuan Zhong, Ting Chen, Tong Zhou, Zengli Zhang, and Minhua Shi. Tpd52l2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. Frontiers in Pharmacology, October 2021. URL: http://dx.doi.org/10.3389/fphar.2021.728420, doi:10.3389/fphar.2021.728420. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2021.728420)

[4. (Chen2017MicroRNA217) Qiuyang Chen, Peng Wang, Yue Fu, Xinchun Liu, Wenbin Xu, Jishu Wei, Wentao Gao, Kuirong Jiang, Junli Wu, and Yi Miao. Microrna-217 inhibits cell proliferation, invasion and migration by targeting tpd52l2 in human pancreatic adenocarcinoma. Oncology Reports, October 2017. URL: http://dx.doi.org/10.3892/or.2017.6036, doi:10.3892/or.2017.6036. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/or.2017.6036)